Method for the treatment and prevention of overweight in mammals
View Patent ↗The present invention relates to a method for the prevention and/or treatment of overweight in mammals. More particularly the invention is concerned with such a method comprising the enteral administration to a mammal of a preparation comprising an effective amount of a combination of dill or an isolate thereof and one or more components capable of stimulating in vivo lipolysis. Suitable examples of components capable of stimulating in vivo lipolysis include methylxanthines, adrenergic amines, Paullinia cupana or an isolate thereof, Zingziber officinale or an isolate thereof, Camellia sinensis or an isolate thereof, Ilex paraguayiensis or an isolate thereof. Another aspect of the invention relates to a solid or semi-solid unit dosage, preferably selected from the group consisting of tablets, pills, microparticles, microspheres, suppositories, capsules, caplets and the like, that is suitable for enteral unitary administration to human subjects and other mammals comprising: a. dill or an isolate thereof in an amount equivalent to between 5 mg and 20 g dill and b. a component capable of stimulating in vivo lipolysis.
1. A solid or semisolid unit dosage selected from the group consisting of tablets, pills, microparticles, microspheres, suppositories, capsules and caplets, that is suitable for enteral unitary administration to human subjects and other mammals comprising:
a. dill or an extract thereof in an amount equivalent to between 5 mg and 20 g dill;
b. between 10 and 4000 mg caffeine; and
c. between 5 mg and 20 g Camellia sinensis.
2. The unit dosage according to claim 1 , wherein the Camellia sinensis is in a daily dosage unit of 0.1 mg –100 mg per kg of body weight.
3. A solid or semi-solid unit dosage for enteral unitary administration to human subjects and other mammals comprising:
a. dill or an extract thereof in an amount equivalent to between 5 mg and 20 g dill;
b. between 10 and 4000 mg caffeine;
c. between 5 mg and 20 g Camellia sinensis ; and
d. a pharmaceutically acceptable carrier.
4. The unit dosage according to claim 3 wherein the Camellia sinensis is in a daily dosage unit of 0.1 mg–100 mg per kg of body weight.
5. A solid or semi-solid unit dosage comprising:
a combination of between 5 mg and 20 g dill or an extract thereof, between 10 and 4000 mg caffeine, and between 5 mg and 20 g Camellia sinensis in a unit form selected from the group consisting of tablets, pills, microparticles, microspheres, suppositories, capsules and caplets.
6. The unit dosage according to claim 5 wherein the Camellia sinensis is in a daily dosage unit of 0.1 mg–100 mg per kg of body weight.